As at 11:00 AM on 8/9/2010
The Share Price is: 27.50 GBX
Home > News
As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:
Interim results for the six months ended 31 January 2006
23 Mar 2006
Biofusion launches Genophrenix
22 Feb 2006
Diurnal Completes Successful Phase I Clinical Study on Chronocort
14 Feb 2006
Simcyp well placed to capitalize on House of Lords drug testing report
08 Feb 2006
Lifestyle Choices launches worlds first triple hormone ovarian reserve test in UK
25 Jan 2006
Biofusion invests in Axordia to expand stem cell programme
20 Jan 2006
Sheffield number one university in UK for stem cell IP
12 Dec 2005
Diurnal starts Phase I trials on Chronocort
07 Dec 2005
New lab for clinical grade stem cells completed in Sheffield
15 Nov 2005
Biofusion expands licensing team
02 Nov 2005